FDA OKs InfraScan's next-gen device to detect brain bleeding

01/22/2013 | MassDevice.com (Boston)

The FDA has granted InfraScan approval for a next-generation version of its Infrascanner, which employs near-infrared technology to allow for the noninvasive detection of bleeding in the brain. The newly approved device, called the Infrascanner Model 2000, was created in collaboration with the U.S. Marine Corps and Navy and has military specifications, but it could also have applications in sports medicine and other fields.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY